Similar Search Results

Lo, Andrew W.; Thakor, Richard T. - In: Annual review of financial economics 14 (2022), pp. 231-270

Persistent link: https://www.econbiz.de/10013461130

Government, policy-making and the development of innovation system : the cases of Taiwanese pharmaceutical biotechnology policies (2000–2008)

Chung, Chao-chen - In: Research policy : policy, management and economic … 42 (2013) 5, pp. 1053-1071

Persistent link: https://www.econbiz.de/10009766322

Pharmaceutical innovation : revolutionizing human health

Landau, Ralph (ed.); Achilladelis, Basil (contributor); … - 1999

Persistent link: https://www.econbiz.de/10001423161

Industry studes: pharmaceutical biotechnology

Pisano, Gary P. - In: Technological innovation and economic performance, (pp. 347-366). 2002

Persistent link: https://www.econbiz.de/10001750819

Cost of Capital for Pharmaceutical, Biotechnology, and Medical Device Firms

Harrington, Scott E. - 2014

, biotechnology, and medical device sectors using data for firms with publicly-traded stock on U.S. exchanges during 2001-2005 and … equity, and the intensity of firms' R&D expenditures. Controlling for firms' principal sector (pharmaceutical, biotechnology …

Persistent link: https://www.econbiz.de/10013070526

The two faces of inventions : the relationship between recombination and impact in pharmaceutical biotechnology

Keijl, S.; Gilsing, Victor A.; Knoben, J.; Duysters, Geert - In: Research policy : policy, management and economic … 45 (2016) 5, pp. 1061-1074

Persistent link: https://www.econbiz.de/10011598745

Manning, Richard L. - In: International journal of the economics of business 25 (2018) 1, pp. 157-166

Persistent link: https://www.econbiz.de/10011881466

Cost of Capital for Pharmaceutical, Biotechnology, and Medical Device Firms

Harrington, Scott E. - In: The Oxford handbook of the economics of the …. 2012

Persistent link: https://www.econbiz.de/10012881697

Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products : the case of Sri Lanka's patent law

Fernando, Ruwan - 2023

-Related Aspects of Intellectual Property Rights (TRIPS) and its biotechnology/pharmaceutical policy guidelines. This approach that is …

Persistent link: https://www.econbiz.de/10014324836

One lab, two firms, many possibilities : on R&D outsourcing in the biopharmaceutical industry

Billette de Villemeur, Étienne; Versaevel, Bruno - In: Journal of health economics 65 (2019), pp. 260-283

Persistent link: https://www.econbiz.de/10012224616

1
2
3
4
5
6
7
8
9
10
Next
Last